Month: November 2022

Urinary Formic Acid: A Promising Alzheimer’s Biomarker!

Imagine if someone spilled a bunch of formaldehyde in your brain, causing all sorts of trouble. Well, that seems to be what happens in Alzheimer’s disease (AD). But guess what? Scientists have discovered a potential new way to spot this disorder early on: urinary formic acid! In a recent study, researchers investigated the relationship between […]

Published on November 30, 2022

Exploring the Role of Neurexin 2 Alpha Variant in Parkinson’s Disease Pathobiology

Imagine unraveling the secrets of Parkinson’s disease by studying a specific variant, p.G849D, in the neurexin 2 alpha protein. This variant could hold valuable insights into the biological pathways underlying the disease. In this study, scientists transfected wild-type and mutant NRXN2α plasmids into SH-SY5Y cells, extracting total protein for mass spectrometry analysis. The results were […]

Published on November 30, 2022

SCD and POD Relationship Explored in Total Hip Replacement Study

Imagine you’re rearranging your kitchen and trying to figure out the best layout. You want to know if moving the toaster closer to the knives could potentially cause more accidents. In a similar vein, researchers investigated the relationship between subjective cognitive decline (SCD) and postoperative delirium (POD) in patients undergoing total hip replacement. They found […]

Published on November 30, 2022